INTEGRATED ANALYSIS OF SOMATIC GENOMIC MUTATIONS AND ANTIGEN PRESENTATION AS PREDICTIVE BIOMARKERS FOR COMBINATION IMMUNOTHERAPY IN KIDNEY CANCER
$663,077FY2020Defense Health AgencyDOD
Sloan-Kettering Institute For Cancer Research
Sloan-Kettering Institute For Cancer Research